Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
There is no real meat behind this one at the moment. Very skeptical. No websites, nothing.
Watch this one. Could go up or down in a hurry.
The thing with FDA approval stocks, there is no warning or gradual run. Once the news hits, I've seen stocks run 500% to 1000% in a matter of a day or hours.
Get FDA approval, I've seen numerous stocks that go up 5 to 10 fold in a matter of days. Go from having zero revenues to a product producing thousands or millions in revenues.
If they were not taking this seriously or expecting to get FDA approval, I personally don't think they would be wasting time giving us updates. I think they would just be dumping huge amounts of shares, dropping the price, and really not caring about the shareholders or price of the stock.
I'm not an expert in getting FDA approval or knowing what labs are considered the best in that regards. Based on what the company stated in one of their recent PRs, “We are pleased to announce that we anticipate completion of the response to the FDA’s request for more information by the end of March.” To facilitate the response, Medifirst has engaged an industry leading laboratory and testing facility that employs over 38,000 people in 1,000 locations in over 100 countries. They hold extensive global accreditations, recognitions, and agreements and their knowledge and expertise is in overcoming regulatory, market, and supply chain hurdles. I think they have a very high percentage of getting approval.
Oh but we will. This thing moves so easily with the very low float and OS. We should be getting another shareholder update before the month is over informing us they responded to the FDA. Then it's just waiting for approval status. I really like how management has been keeping us informed lately. I see an absolute HUGE very short term catalyst being FDA approval. If that's the case, this could easily move up to a nickel or dime in very short time.
Agreed. This is going down on super low volume. That tells me manipulation and very little dilution (if any at all). This is due for a major reversal very, very soon.
They only had one extension. And they are expediting the process of giving the FDA response.
Are you kidding me? They have filed their Time Machine, laser unit, with the FDA. And with regards to no revenue, it's called the DEVELOPMENT stage. Drug companies have the same stages. If they get FDA, which we should find out very soon, will go from zero revenue to thousands or millions in revenue.
The chart has been trading sideways the past few days. Very low volume in anticipation of FDA news. RSI is primed for a huge run and this is a very low float stock.
The real fireworks haven't even started yet. Wait until we find out about FDA approval. Then the real fireworks start. We go from zero revenues to possibly having thousands or more likely millions.
Meaning we should get another shareholders update informing us they submitted the response, meaning more news. FDA approval could happen anytime after.
Meaning less than a month. And that's at the latest, could be a couple weeks ;)
This is what I was afraid of. Like I said early, I had a sneaky suspicion that it was going to top out today.
It was their first response by the FDA which is more common than not common. They are expediting their answer. Enough said.
And again even though they have $30 million in cash, they have $70 million in debt they have to pay. Also, the business model it is, is producing negative operating income and it's growing quarter versus quarter. Their gross profit margin is not very good, meaning they are not pricing their products high enough. And they can't raise their product prices as sales has continued to decrease. This company would be completely different if it was increasing sales quarter over quarter.
I have to admit, I missed the boat on this one the past couple of weeks. But at the current pps, I find it very risk to get in as we get closer to the shareholder meeting and also get closer to a penny. People are saying once this hits a penny, that allows dilution to start again.
Very well said. This is about to become a dilution nightmare!!
For the nine months ended September 30th,
2015:
-8,650,465 (OPERATING LOSS)
2014:
-6,506,982 (OPERATING LOSS)
2015:
Total Sales - 7,359,069
2014:
Total Sales - 13,547,792
Sales DECLINING
OPERATING LOSS has continued to increase while sales has continued to DECREASE.
You have to ask yourself how much is a company worth that has continually produced NEGATIVE OPERATING INCOME and owes loan sharks $70 million in DEBT on April 15th. This has run on hype and is very soon to come to an end. It might have already started.
"Dumping" would mean high volume days, especially high buying volume" with a declining price. This is far from that.
Which it sounds like the shareholders will vote on March 15 and the RS can't happen until April 15. I think most people believe that the shareholders will indeed vote for a RS to get to a higher exchange.
Can somebody please elaborate on this?
I suspect we will get another updated shareholder letter before the month is over to inform us they have answered the FDA's questions. Then it could literally be days or weeks before we find out if we are getting FDA approval!!!!!
Things should starting heating up this month.
This is reminding me more and more of strike force.
Just look at how another health care company shot up today, NUU*. There wasn't even any big news. Now imagine this ticker with FDA approval. We go from having zero revenue to in the millions most likely.
Yep, no matter how you look at it, that's a considerable amount of money. I believe most of us knows what will happen. It will RS to get the price higher and then the major dumping begins.
I'm guessing that the review process will not take long once the company provides answers to the additional questions by the FDA.
This is definitely a gamble, but if the company does get FDA approval, I could very well see the pps going up at least 10x within a month or so. They would go from having no revenue, to millions. All the upfront R&D costs would be recouped in a short amount of time.
I like that the FDA approval process is being expedited.
I understand in OTC land that's a long time. But still, with possible major dilution starting back up and a RS occurring around April 15th, I don't see a whole lot of short to midterm value with this company.
Nothing wrong with that. I'm just honestly a little surprised at how hard this is running. The shareholders will most likely vote on a RS that will then occur on April 15th and warrants will eventually start being converted. 99% of OTC stocks don't react well to RS as that will just setup for more dumping from the warrants.
I'm not sure why is running so hard when the shareholder's meeting is right around the corner. It sounds like most likely a RS is going to happen. Usually RS always crush OTC stocks. Will somebody please elaborate?
You think after the shareholder meeting this will collapse if they vote on a RS?
Agreed. The chart is looking really good and held up very well on Friday.
There appears to be a lot interest in this stock again. Any decent news and this should pop big time. I will be watching very closely on Monday to see if this can hold above .005.
Sorry but just don't see it with this stock. Lost a lot of faith with all the dilution.
Just don't know about this one. I still think there is some major dilution going on. In addition, the problem is people are not holding on very long to this stock. They bought in the high .003s and sold in the .005s. I will keep a close eye on this stock but not touching it for now until some major news gets released.
Do we know how many CDs are coming due anytime soon?
Great day in my opinion. Only down 8.5% on a Friday is not bad at all. Seems to be consolidating very well at this level. I wouldn't be surprised at all to break into the .02s early next week. FDA approval could be a game changer and who knows where the price will end up.
Not looking good.
Down to .0044 bid. Not much support.